Intelligence Platform

Patents

Browse 21 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12178860

Hyaluronidase enzyme formulations for high volume administration

HALOZYME, INC. · Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11723959

Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase p

HALOZYME, INC. · Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10898551

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10328130

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

HALOZYME, INC. · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10286044

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9677061

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9677062

Hyaluronidase and factor VIII compositions

HALOZYME, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562223

Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycopr

HALOZYME, INC. · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8772246

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765685

Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)

HALOZYME, INC. · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450470

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431380

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431124

Methods for treating a disease characterized by an excess of hyaluronan by administering a

HALOZYME, INC. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202517

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7781397

Human plasma hyaluronidase

The Regents of the University of California · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7767429

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7148201

Use of human plasma hyaluronidase in cancer treatment

The Regents of the University of California · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7105330

Human plasma hyaluronidase

The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6193963

Method of treating tumor-bearing patients with human plasma hyaluronidase

The Regents of the University of California · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6123938

Human urinary hyaluronidase

The Regents of the University of California · Granted Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6103525

Hybridoma cell lines producing monoclonal antibodies that bind to human plasma hyaluronida

The Regents of the University of California · Granted Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired